GlassScriptPhysician profile
Kathryn M Donovan
NPI 1700575099
$2,878.14
in general payments reported to CMS, 2019-2025
22 companies · $511 in 2025
The $511 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,523 · 2024: $844 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,821 · Travel and Lodging: $1,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,821.44 |
| Travel and Lodging | $1,056.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,290.66 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $362.87 | 2024-2025 | Hawkone, Plasmablade(Tm), Corevalve Evolut R |
| Atricure, INC. | $257.61 | 2024-2025 | Synergy Ablation System |
| E.R. Squibb & Sons, L.L.C. | $176.68 | 2024-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $173.10 | 2023-2025 | Watchman Flx, Enroute Transcarotid Neuroprotection System |
| Merck Sharp & Dohme LLC | $75.06 | 2023-2025 | Verquvo, Capvaxive |
| Imperative Care, INC | $67.31 | 2024 | Prodigy Catheter |
| Silk Road Medical, INC. | $66.00 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Abbott Laboratories | $59.50 | 2024-2025 | Cardiomems, Navitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.93 | 2023-2025 | Jardiance |
| Cvrx, INC. | $51.71 | 2024-2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $36.91 | 2023-2024 | Andexxa, Wainua |
| Actelion Pharmaceuticals US, INC. | $35.20 | 2025 | Opsumit, Uptravi |
| Cardiva Medical, INC. | $29.63 | 2024 | Savvywire |
| Edwards Lifesciences Corporation | $28.02 | 2024 | Mitris Resilia Mitral Valve |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $22.60 | 2023 | Ostene |
| Smith+Nephew, INC. | $21.87 | 2025 | Renasys Touch |
| Inspire Medical Systems, INC. | $18.13 | 2024 | Inspire |
| G Medical Diagnostic Services, INC. | $16.58 | 2024 | Cardiac Monitoring Suite |
| Irhythm Technologies, INC. | $16.08 | 2024 | Zio Xt Patch, Zio Monitor |
| Lemaitre Vascular, INC. | $11.49 | 2023 | Hydro Lemaitre Valvulotome |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.20 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Donovan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.